Department of Radiation and Cellular Oncology
Behzad Ebrahimi is interested in developing models to predict progression of diseases and response to treatments, using information from quantitative physiological and molecular imaging techniques. His research seeks to identify critical interplay and fundamental rules that determine outcomes. Such analytical methods generally demand assessment of biomarkers with high levels of accuracy and precision. Through this work, he has developed new methods or improved current techniques to measure markers associated with hypoxia, oxidative stress, impaired perfusion, and tissue remodeling.
His work has been published in Investigative Radiology, Radiology, and Journal of Cardiovascular Magnetic Resonance.
Ebrahimi earned MS and PhD degrees in biomedical engineering from the University of Michigan and a BS in physics from the University of Tehran. He pursued a postdoctoral research fellowship at Mayo Clinic, where he received the Outstanding Research Fellow Award. He completed his postdoctoral study at Massachusetts General Hospital of Harvard Medical School. Most recently, he was a medical physics resident at the University of Miami Health System’s Sylvester Comprehensive Cancer Center.